Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets.

prnasiaJuly 30, 2021

Tag: Neukio , LAV , IDG , Sherpa , iPSC-CAR-NK

PharmaSources Customer Service